NR4A1 and breast carcinoma: Although receptor targeting interventions for breast cancer treatment have shown positive outcomes for hormone receptor positive breast cancers, the lack of such specific targets in TNBCs leaves patients with only chemotherapy as the standard option for treatment [5].